← Open Payments lookup

JILL EASLEY: Open Payments

NPI 1891100970 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,984 in 136 payments from 29 companies in 2025. Trend: 2023 $3,060 · 2024 $2,650 · 2025 $2,984

Food & beverage: $2,984
CompanyPaymentsAmount
ABBVIE INC.23$404
Astellas Pharma US Inc10$339
Axsome Therapeutics, Inc.4$240
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$229
AstraZeneca Pharmaceuticals LP14$222
PFIZER INC.10$203
Lilly USA, LLC19$199
Novo Nordisk Inc9$173
Teva Pharmaceuticals USA, Inc.1$124
Abbott Laboratories1$114

Products named: Veozah, UBRELVY, XIFAXAN, Auvelity, FARXIGA, NURTEC ODT, MOUNJARO, REXULTI.

Industry payments across MS — which companies pay providers there.